Fabian Basler

Fabian Basler

Auto-generated profile, based on publicly available information

Fabian Basler

Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital, University of Cologne, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2025 in Journal of Neurochemistry
Verified
Journal Article
Open access
NBNele Burdina
Nele Burdina
FLFilip Liebsch
Filip Liebsch
AMArthur Macha
Arthur Macha
JGJoaquín Lucas Ortuño Gil
Joaquín Lucas Ortuño Gil
PFPia Frommelt
Pia Frommelt
Günter SchwarzGünter Schwarz
Günter Schwarz
Gephyrin is the main scaffolding protein at inhibitory synapses, clustering glycine and GABAA receptors. At specific GABAergic synapses, the nucleotide exchange factor collybistin recruits gephyrin to the postsynaptic membrane via interaction with phosphoinositides. However, the molecular mechanisms underlying the formation, maintenance, and regulation of collybistin‐dependent gephyrin clusters remain poorly understood. This study sheds light on the molecular mechanism of gephyrin cluster formation on the basis of gephyrin self‐oligomerization induced by collybistin, leading to the formation of a high‐molecular weight (> 5 MDa) gephyrin‐collybistin complex, which is regulated in two ways: First, plasma‐membrane phosphoinositides promote complex formation, demonstrating their critical role in membrane targeting and stabilization of gephyrin‐collybistin clusters at postsynaptic sites. Second, gephyrin phosphorylation at Ser325 abolishes complex formation with collybistin, thus impairing collybistin‐dependent gephyrin clustering at GABAergic synapses. Collectively, our data demonstrate a molecular mechanism for synaptic clustering of gephyrin, which involves collybistin‐ and phosphoinositide‐dependent formation of high‐molecular weight gephyrin oligomers. image

2 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
TRTill Rüngeler
Till Rüngeler
EPEgor Pavlenko
Egor Pavlenko
FBFabian Basler
Fabian Basler
JRJuliane Renn
Juliane Renn
FKFarnusch Kaschani
Farnusch Kaschani
SPSimon Poepsel
Simon Poepsel
Trimethylation of lysine 4 of histone H3 (H3K4me3) is a post-translational modification (PTM) enriched at promoters of actively transcribed genes. H3K4me3 is removed by the human histone demethylases of the KDM5 family. KDM5 demethylases act as transcriptional repressors through their catalytic activity in addition to more complex roles that depend on their interactions with other chromatin regulators and may be independent of demethylase activity. To better understand the mechanistic differences of the closely related paralogs KDM5A and KDM5B as well as their interactions with Retinoblastoma protein (RB), we systematically analyzed and compared their demethylase activities, nucleosome engagement, and RB binding. We used recombinant nucleosome binding and demethylase activity assays, as well as an integrative structural biology approach using negative-stain electron microscopy (EM), AlphaFold predictions, and cross-linking mass spectrometry for a comprehensive in vitro analysis of these critical and largely non-redundant enzymes. KDM5A and KDM5B showed differences in enzyme kinetics using peptide substrates, as well as in nucleosome binding. Furthermore, KDM5A interacts with RB, mainly mediated by its canonical LxCxE RB binding motif. KDM5B, on the other hand, lacks an LxCxE binding motif and does not stably bind to RB under the conditions tested here. RB directly interacts with nucleosomes, and its nucleosome binding does not measurably affect KDM5A demethylase activity or nucleosome interactions. Our findings provide a biochemical framework for the differences between KDM5A and KDM5B regarding RB interactions and nucleosome engagement.